Swiss pharma company plans SCOTUS appeal

Novartis will seek a review of the Federal Circuit’s decision regarding a multiple sclerosis treatment.

EMA backs switch to biosimilars

The European Medicines Agency has decided that medicines approved as biosimilars may be prescribed interchangeably, without the need for additional studies.

Powell Gilbert hires life sciences patent litigator

The IP law firm has expanded its life sciences team with the appointment of James Bergus, who joins from the Federal Court of Australia.

LSIPR